CAS 936091-14-4
:TG101209
Description:
TG101209, with the CAS number 936091-14-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain protein kinases involved in various cellular processes. The compound exhibits a unique structure that contributes to its biological activity, often characterized by specific functional groups that enhance its binding affinity to target proteins. TG101209 has been studied for its role in modulating signaling pathways associated with cancer and other diseases, making it a subject of interest in drug development. Its solubility, stability, and pharmacokinetic properties are critical for its efficacy and safety profile in preclinical and clinical studies. As research continues, understanding the mechanism of action and potential side effects of TG101209 will be essential for evaluating its therapeutic potential and advancing its application in clinical settings.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
TG101209
CAS:<p>TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM.</p>Formula:C26H35N7O2SPurity:99% - >99.99%Color and Shape:SolidMolecular weight:509.67TG101209-d9
CAS:Controlled Product<p>Applications TG101209-d9 is the isotope labelled analog of TG101209 (T337900); an effective tyrosine kinase inhibitor of tyrosine kinases JAK2 and JAK3 (janus kinase 2/3), inducing cell arrest and apoptosis in leukemia cell lines.<br>References Samanta, A. et al.: Leukemia, 25, 463 (2011); Traer, E. et al.: Leukemia, 26, 1140 (2012); Ramakrishnan, V. et al.: Am. J. Hematol., 85, 675 (2010)<br></p>Formula:C26D9H26N7O2SColor and Shape:NeatMolecular weight:518.722
